Why do drug companies make no effort on the study of RAS?
A.
Because they can't find how medicine can take effect on RAS.
B.
Because RAS is often mutated and changes forms.
C.
Because it doesn't seem to be of vital importance on treating cancers.
D.
Because RAS binds firmly with cells and are inseparable.